Citations (57)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Hengye Chen, Muhammad Safiullah Virk & Fusheng Chen. (2016) Phenolic acids inhibit the formation of advanced glycation end products in food simulation systems depending on their reducing powers and structures. International Journal of Food Sciences and Nutrition 67:4, pages 400-411.
Read now
Read now
Giancarlo Aldini, Giulio Vistoli, Milan Stefek, N. Chondrogianni, Tilman Grune, Jolanta Sereikaite, Izabela Sadowska-Bartosz & Grzegorz Bartosz. (2013) Molecular strategies to prevent, inhibit, and degrade advanced glycoxidation and advanced lipoxidation end products. Free Radical Research 47:sup1, pages 93-137.
Read now
Read now
Daxin Li, Shinya Mitsuhashi & Makoto Ubukata. (2012) Protective effects of hesperidin derivatives and their stereoisomers against advanced glycation end-products formation. Pharmaceutical Biology 50:12, pages 1531-1535.
Read now
Read now
Kei Fukami, Mark E Cooper & Josephine M Forbes. (2005) Agents in development for the treatment of diabetic nephropathy. Expert Opinion on Investigational Drugs 14:3, pages 279-294.
Read now
Read now
Articles from other publishers (53)
Guillermo García-Díez & Nelaine Mora-Diez. (2020) Theoretical Study of the Iron Complexes with Aminoguanidine: Investigating Secondary Antioxidant Activity. Antioxidants 9:8, pages 756.
Crossref
Crossref
Guillermo García-Díez, Rafael Ramis & Nelaine Mora-Diez. (2020) Theoretical Study of the Copper Complexes with Aminoguanidine: Investigating Secondary Antioxidant Activity. ACS Omega 5:24, pages 14502-14512.
Crossref
Crossref
Serhii Vakal, Sirpa Jalkanen, Käthe M. Dahlström & Tiina A. Salminen. (2020) Human Copper-Containing Amine Oxidases in Drug Design and Development. Molecules 25:6, pages 1293.
Crossref
Crossref
Jing Xiang, Qian-Qian Su, Li-Juan Luo & Tai-Chu Lau. (2019)
Synthesis and reactivity of an osmium(
iii
) aminoguanidine complex
. Dalton Transactions 48:30, pages 11404-11410.
Crossref
Crossref
Anna Voloshenko Rossin, Sergey Sladkevich, Guy Gasser, Artem Melman & Ovadia Lev. (2017) Sensitive Analysis of Nitroguanidine in Aqueous and Soil Matrices by LC-MS. Analytical Chemistry 89:18, pages 9990-9996.
Crossref
Crossref
Marie Frimat, Maité Daroux, Rachel Litke, Rémi Nevière, Frédéric J. Tessier & Eric Boulanger. (2017) Kidney, heart and brain: three organs targeted by ageing and glycation. Clinical Science 131:11, pages 1069-1092.
Crossref
Crossref
Tao Chen, Xiao-Li Sun, Xi-Ai Yang, Jing-Jing Shi, Yi Liu & Jia-Ming Gong. (2017) Aminoguanidine exhibits an inhibitory effect on β-amyloid-induced damage in F98 glioma cells. Molecular Medicine Reports 16:5, pages 6116-6121.
Crossref
Crossref
Iraj Sarvi, Mostafa Gholizadeh & Mohammad Izadyar. (2017) Highly Dispersed Palladium Nanoparticle-Loaded Magnetic Catalyst (FeS@EP–AG–Pd) for Suzuki Reaction in Water. Catalysis Letters 147:5, pages 1162-1171.
Crossref
Crossref
Gaohong Lv, Xing Lv, Yuhan Tao & Huiqin Xu. (2016) Effect of morroniside on glomerular mesangial cells through AGE–RAGE pathway. Human Cell 29:4, pages 148-154.
Crossref
Crossref
Junbiao Wu, Bihao Liu, Chunling Liang, Hui Ouyang, Jin Lin, Yanchun Zhong, Yu He, Jie Zhou, Yuan Zhou & Jiuyao Zhou. (2016) Zhen-wu-tang attenuates cationic bovine serum albumin-induced inflammatory response in membranous glomerulonephritis rat through inhibiting AGEs/RAGE/NF-κB pathway activation. International Immunopharmacology 33, pages 33-41.
Crossref
Crossref
Cláudia de Souza Ferreira, Paula Commune Pennacchi, Tomaz Henrique Araújo, Noemi Nosomi Taniwaki, Fernanda Borges de Araújo Paula, Stella Maris da Silveira Duarte & Maria Rita Rodrigues. (2016) Aminoguanidine treatment increased NOX2 response in diabetic rats: Improved phagocytosis and killing of Candida albicans by neutrophils. European Journal of Pharmacology 772, pages 83-91.
Crossref
Crossref
Meha Fatima Aftab, Shabbir Khan Afridi, Safina Ghaffar, Munazza Murtaza, Momin Khan, Aneela Karim, Khalid Mohammed Khan & Rizwana Sanaullah Waraich. (2015) A bis-Schiff base of isatin improves methylglyoxal mediated insulin resistance in skeletal muscle cells. Archives of Pharmacal Research.
Crossref
Crossref
Leilei Wang, Ning Wang, Hor-yue Tan, Yinjian Zhang & Yibin Feng. (2015) Protective effect of a Chinese Medicine formula He-Ying-Qing-Re Formula on diabetic retinopathy. Journal of Ethnopharmacology 169, pages 295-304.
Crossref
Crossref
Alipour MohsenGhadiri Soufi FarhadJafari Mohammad-Reza. (2014) Effect of aminoguanidine on sciatic functional index, oxidative stress, and rate of apoptosis in an experimental rat model of ischemia–reperfusion injury. Canadian Journal of Physiology and Pharmacology 92:12, pages 1013-1019.
Crossref
Crossref
Samuel Snyder, Gracie A. Turner & Alan Turner. (2014) Obesity-related Kidney Disease. Primary Care: Clinics in Office Practice 41:4, pages 875-893.
Crossref
Crossref
Victor Gueutin, Marion Gauthier, Maud Cazenave & Hassane Izzedine. (2014) Néphropathie diabétique : traitements émergents. Néphrologie & Thérapeutique 10:4, pages 210-215.
Crossref
Crossref
ZONGSHU LI, JUAN DU, HONGXIA SUN, JING MANG, JINTING HE, JIAOQI WANG, HONGYU LIU & ZHONGXIN XU. (2014) Effects of the combination of methylprednisolone with aminoguanidine on functional recovery in rats following spinal cord injury. Experimental and Therapeutic Medicine 7:6, pages 1605-1610.
Crossref
Crossref
Katja Karjalainen, Renata Pasqualini, Jorge E. Cortes, Steven M. Kornblau, Benjamin Lichtiger, Susan O'Brien, Hagop M. Kantarjian, Richard L. Sidman, Wadih Arap & Erkki Koivunen. (2014) Design, development, and validation of a high-throughput drug-screening assay for targeting of human leukemia. Cancer 120:4, pages 589-602.
Crossref
Crossref
R. E. Khoma, V. O. Gelmboldt, V. N. Baumer, O. V. Shishkin & L. V. Koroeva. (2013) Synthesis and structure of aminoguanidinium sulfite monohydrate. Russian Journal of Inorganic Chemistry 58:7, pages 843-847.
Crossref
Crossref
Yan-Ying Liu, Bhushan Vijay Nagpure, Peter T.-H Wong & Jin-Song Bian. (2013) Hydrogen sulfide protects SH-SY5Y neuronal cells against d-galactose induced cell injury by suppression of advanced glycation end products formation and oxidative stress. Neurochemistry International 62:5, pages 603-609.
Crossref
Crossref
Deanna S. Kania, Cory T. Smith, Christy L. Nash, Jasmine D. Gonzalvo, Andrea Bittner & Brian M. Shepler. (2013) Potential New Treatments for Diabetic Kidney Disease. Medical Clinics of North America 97:1, pages 115-134.
Crossref
Crossref
B. Dupas, P. Massin, A. Gaudric & M. Paques. (2012) Épidémiologie et physiopathologie de la rétinopathie diabétique. EMC - Endocrinologie - Nutrition 9:3, pages 1-9.
Crossref
Crossref
Emaad M. Abdel-Rahman, Lawand Saadulla, W. Brian Reeves & Alaa S. Awad. (2011) Therapeutic Modalities in Diabetic Nephropathy: Standard and Emerging Approaches. Journal of General Internal Medicine 27:4, pages 458-468.
Crossref
Crossref
Andreea Iren Serban, Marieta Costache & Anca Dinischiotu. (2011) Controversial behavior of aminoguanidine in the presence of either reducing sugars or soluble glycated bovine serum albumin. Carbohydrate Research 346:18, pages 2872-2880.
Crossref
Crossref
Vinicius F. Carvalho, Luisa T. Florim, Emiliano de O. Barreto, Rafael C. Torres, Marcelo M. Batista, Fabio C. Amendoeira, Renato S.B. Cordeiro, Marco A. Martins & Patrícia M.R. e Silva. (2011) Inhibition of advanced glycation end products by aminoguanidine restores mast cell numbers and reactivity in alloxan-diabetic rats. European Journal of Pharmacology 669:1-3, pages 143-148.
Crossref
Crossref
Mohsen Alipour, Mohammad Reza Gholami, Iraj Jafari Anarkooli, Davood Sohrabi, Javad Tajki & Maryam Pourheidar. (2011) Intraperitoneal Aminoguanidine Improves Sciatic Nerve Ischemia–Reperfusion Injury in Male Sprague-Dawley Rats. Cellular and Molecular Neurobiology 31:5, pages 765-773.
Crossref
Crossref
Aaron P. McGrath, Tom Caradoc-Davies, Charles A. Collyer & J. Mitchell Guss. (2010) Correlation of Active Site Metal Content in Human Diamine Oxidase with Trihydroxyphenylalanine Quinone Cofactor Biogenesis,. Biochemistry 49:38, pages 8316-8324.
Crossref
Crossref
A.H. Subratty, N. Aukburally, V. Jowaheer & N. Joonus. (2010)
Vitamin C and urea inhibit the formation of advanced glycation end products
in vitro
. Nutrition & Food Science 40:5, pages 456-465.
Crossref
Crossref
Zhong-kai Fan, Yan-feng Wang, Yang Cao, Ming-chao Zhang, Zheng Zhang, Gang Lv, Wei Lu & Yu-qiang Zhang. (2010) The effect of aminoguanidine on compression spinal cord injury in rats. Brain Research 1342, pages 1-10.
Crossref
Crossref
Faruk Turgut & Warren Kline Bolton. (2010) Potential New Therapeutic Agents for Diabetic Kidney Disease. American Journal of Kidney Diseases 55:5, pages 928-940.
Crossref
Crossref
Mark E. Williams & Robert Stanton. 2010. Chronic Kidney Disease, Dialysis, and Transplantation. Chronic Kidney Disease, Dialysis, and Transplantation
39
56
.
Sean M. Sliman, Timothy D. Eubank, Sainath R. Kotha, M. Lakshmi Kuppusamy, Shariq I. Sherwani, Elizabeth Susan O’Connor Butler, Periannan Kuppusamy, Sashwati Roy, Clay B. Marsh, David M. Stern & Narasimham L. Parinandi. (2009) Hyperglycemic oxoaldehyde, glyoxal, causes barrier dysfunction, cytoskeletal alterations, and inhibition of angiogenesis in vascular endothelial cells: aminoguanidine protection. Molecular and Cellular Biochemistry 333:1-2, pages 9-26.
Crossref
Crossref
Wei Hao, Xi-qiang Wu & Rong-tian Xu. (2009) The molecular mechanism of aminoguanidine-mediated reduction on the brain edema after surgical brain injury in rats. Brain Research 1282, pages 156-161.
Crossref
Crossref
Wei-bing Xu, Gang Lv, Yan-feng Wang, Xu-hua Lu, Tao Huang, Yue Zhu & Lian-shun Jia. (2009) Combination of Dexamethasone and Aminoguanidine Reduces Secondary Damage in Compression Spinal Cord Injury. Cellular and Molecular Neurobiology 29:5, pages 683-689.
Crossref
Crossref
. 2009. Copper Amine Oxidases. Copper Amine Oxidases
279
323
.
O. A. Bizzozero. 2009. Handbook of Neurochemistry and Molecular Neurobiology. Handbook of Neurochemistry and Molecular Neurobiology
543
562
.
Fan Di, Gu Yan-ting, Lv Hui, Tang Tao, Xu Zai-hua, Shi Xue-ying, Xue Hong-li & Wang Yun-jie. (2008) Role of aminoguanidine in brain protection in surgical brain injury in rat. Neuroscience Letters 448:2, pages 204-207.
Crossref
Crossref
Abedin Vakili, Fezzeh Hosseinzadeh & Toktam Sadogh. (2007) Effect of aminoguanidine on post-ischemic brain edema in transient model of focal cerebral ischemia. Brain Research 1170, pages 97-102.
Crossref
Crossref
David J. Aitken, Alberto Albinati, Arnaud Gautier, Henri‐Philippe Husson, Georges Morgant, Dung Nguyen‐Huy, Jiří Kozelka, Pascale Lemoine, Sandrine Ongeri, Silvia Rizzato & Bernard Viossat. (2007)
Platinum(II) and Palladium(II) Complexes with
N
‐Aminoguanidine
. European Journal of Inorganic Chemistry 2007:21, pages 3327-3334.
Crossref
Crossref
Vincent Chan, Andrew Hoey & Lindsay Brown. (2006) Improved cardiovascular function with aminoguanidine in DOCA-salt hypertensive rats. British Journal of Pharmacology 148:7, pages 902-908.
Crossref
Crossref
Mark E Williams. (2006) New Potential Agents in Treating Diabetic Kidney Disease. Drugs 66:18, pages 2287-2298.
Crossref
Crossref
Mark F. McCarty. (2006) Adjuvant strategies for prevention of glomerulosclerosis. Medical Hypotheses 67:6, pages 1277-1296.
Crossref
Crossref
KARIN A. JANDELEIT‐DAHM, MARKUS LASSILA & TERRI J. ALLEN. (2006) Advanced Glycation End Products in Diabetes‐Associated Atherosclerosis and Renal Disease: Interventional Studies. Annals of the New York Academy of Sciences 1043:1, pages 759-766.
Crossref
Crossref
Mark E. Williams & Katherine R. Tuttle. (2005) The next generation of diabetic nephropathy therapies: An update. Advances in Chronic Kidney Disease 12:2, pages 212-222.
Crossref
Crossref
Armando Rojas & Miguel A. Morales. (2004) Advanced glycation and endothelial functions: A link towards vascular complications in diabetes. Life Sciences 76:7, pages 715-730.
Crossref
Crossref
Mark E. Williams. (2004) Clinical studies of advanced glycation end product inhibitors and diabetic kidney disease. Current Diabetes Reports 4:6, pages 441-446.
Crossref
Crossref
Mustafa F. Usta, Trinity J. Bivalacqua, I. Turker Koksal, Behiye Toptas, Sibel Surmen & Wayne J.G. Hellstrom. (2004) The protective effect of aminoguanidine on erectile function in diabetic rats is not related to the timing of treatment. BJU International 94:3, pages 429-432.
Crossref
Crossref
Shi-Fang Yan, Ravichandran Ramasamy, Loredana G Bucciarelli, Thoralf Wendt, Larisse K Lee, Barry I Hudson, David M Stenr, Evanthia Lalla, Shi Du Yan, Ling Ling Rong, Yoshifumi Naka & Ann Marie Schmidt. (2016) RAGE and its ligands: a lasting memory in diabetic complications?. Diabetes and Vascular Disease Research 1:1, pages 10-20.
Crossref
Crossref
Thomas O Metz, Nathan L Alderson, Suzanne R Thorpe & John W Baynes. (2003) Pyridoxamine, an inhibitor of advanced glycation and lipoxidation reactions: a novel therapy for treatment of diabetic complications. Archives of Biochemistry and Biophysics 419:1, pages 41-49.
Crossref
Crossref
Sara Vasan, Peter Foiles & Hank Founds. (2003) Therapeutic potential of breakers of advanced glycation end product–protein crosslinks. Archives of Biochemistry and Biophysics 419:1, pages 89-96.
Crossref
Crossref
Thoralf Wendt, Nozomu Tanji, Jiancheng Guo, Barry I. Hudson, Angelika Bierhaus, Ravichandran Ramasamy, Bernd Arnold, Peter P. Nawroth, Shi Fang Yan, Vivette D’Agati & Ann Marie Schmidt. (2003)
Glucose, Glycation, and RAGE: Implications for Amplification of Cellular Dysfunction in Diabetic Nephropath
y
. Journal of the American Society of Nephrology 14:5, pages 1383-1395.
Crossref
Crossref
Rayaz Malik. (2016) Failure to define the pathogenesis and treatment of human diabetic neuropathy. The British Journal of Diabetes & Vascular Disease 3:2, pages 107-111.
Crossref
Crossref
Paolo Men??Francescaromana Festuccia & Francesco Pugliese. (2003) Clinical Potential of Advanced Glycation End-Product Inhibitors in Diabetes Mellitus. American Journal of Cardiovascular Drugs 3:5, pages 315-320.
Crossref
Crossref